Past CureTalks
The New Optimism of Combination Therapies in Multiple Myeloma Treatment.
Clinical trials of new combination therapies are showing promising results and can be a game changer in myeloma treatment - Combining standard drugs with monoclonal antibodies, t-cell therapies with stem cell transplants, myeloma vaccine combinations and more. We are talking…
Recurrent Miscarriages – Causes and Treatments
Almost half of all pregnancies end in a miscarriage, most of them occurring within few weeks of conception. While there are a number of known risk factors such as maternal age, history of miscarriage, and infertility, there are others like…
Everything you need to know about Daratumumab and Multiple Myeloma
FDA recently approved daratumumab (Darzalex) to treat patients with multiple myeloma who have received atleast three prior treatments. Daratumumab is the first monoclonal antibody approved for treating myeloma and provides another treatment option for patients who have become resistant to…
How Will New Imaging Techniques and Genomic Tests Help In Diagnosis and Management of Prostate Cancer.
Recent advances in prostate cancer has led to the discovery of many new imaging and genomic tests. Information on the new tests and techniques can help patients in making informed decisions regarding their prostate cancer diagnosis, treatments and management options…
Myeloma 2015. Year in Review with the MMRF
2015 saw a lot of action in the Myeloma world. Four new drugs were approved by the FDA increasing treatment options and allowing new combination regimens; promising immunotherapy research results will see these being used in clinical practice and 1000…